Concepedia

Publication | Open Access

Sifalimumab, a Human Anti–Interferon‐α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose‐Escalation Study

DOIFull Paper Access

238

Citations

24

References

2013

Year

Michelle Petri, Daniel J. Wallace, Alberto Spindler, Vishala Chindalore, Kenneth Kalunian, Eduardo Mysler, C. Michael Neuwelt, Gabriel J. Robbie, Wendy I. White, Brandon W. Higgs,
Arthritis & Rheumatism

Abstract

The observed safety/tolerability and clinical activity profile of sifalimumab support its continued clinical development for SLE.

References

YearCitations

Page 1